JP2MRI Video Gallery

 

Video Gallery for the John Paul II Medical Research Institute.

Capital Campaign

 

The John Paul II Medical Research Institute (JP2MRI) is conducting a One Million Dollar Capital Campaign Drive to start the process of developing adult stem cell therapies.

Patient Registry

 

This is a patient registry form for anyone who has a genetic disorder who would like to join. All data will be held confidentially, obtained voluntarily, and will never be shared with third parties. Once you're done, click Submit.

Physician Registry

 

The Institute needs physicians to volunteer to identify and recruit patients to participate in obtaining tissue samples from patients to create induced pluripotent stem (IPS) cells. 

Newsletters

 

Subscribe to our newsletters.

The service of humanity leads us to insist, in season and out of season, that those using the latest advances of science, especially in the field of biotechnology, must never disregard fundamental ethical requirements by invoking a questionable solidary which eventually leads to discriminating between one life and another and ignoring the dignity which belongs to every human being.

St. Pope John Paul II

The John Paul II Medical Research Institute (JP2MRI) focuses on the most ethical and cost-effective way of conducting medical research to help develop therapies and cures for a variety of diseases. Most diseases share a common technical requirement to create therapies. The Institute’s research focuses on these common technical requirements by recruiting patients to procure tissue to develop stem cells and cancer cells for medical research.

 

The Institute differentiates itself from other research organizations in the following manner:

 

1. We do NOT support embryonic stem cell research. We support research that is pro-life driven.

 

2. We devote more than half of our budget towards medical research, which is far greater than most established foundations.

 

We need your support now.

© 2019 John Paul II Medical Research Institute.